Literature DB >> 1167043

Effect of inoculum and of beta-lactamase on the anti-staphylococcal activity of thirteen penicillins and cephalosporins.

L D Sabath, C Garner, C Wilcox, M Finland.   

Abstract

Because there are few persuasive data for selecting one semisynthetic penicillin or cephalosporin over another for treatment of serious staphylococcal infections, 118 recent clinical isolates of Staphylococcus aureus were studied to determine to what extent the presence of beta-lactamase affected the relative anti-staphylococcal activity of six penicillins and seven cephalosporins. In addition, the effect of inoculum was studied for its possible effect on the anti-staphylococcal activity of the 13 beta-lactam antibiotics. By all criteria, methicillin and nafcillin were clearly more resistant to both the inoculum effect and the production of staphylococcal beta-lactamase, whereas benzylpenicillin and cephaloridine (especially benzyl-penicillin) were the most susceptible to these effects. Cephazolin was clearly more susceptible to staphylococcal beta-lactamase and heavy inocula than the other cephalosporins (with the exception of cephaloridine), whereas cephalothin was the most resistant cephalosporin to these factors. The minimal inhibitory concentration for benzylpenicillin for tests with undiluted inoculum, compared to results with inoculum diluted 10(-4), differed by a factor up to 16,384, whereas with methicillin and nafcillin the differences were rarely more than twofold. Ratios for the other 10 antibiotics fell between these extremes. These results suggest that methicillin or nafcillin is most stable to staphylococcal beta-lactamase, and that benzylpenicillin and cephaloridine are the most susceptible.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1167043      PMCID: PMC429316          DOI: 10.1128/AAC.8.3.344

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  10 in total

1.  OXACILLIN TREATMENT OF SEVERE STAPHYLOCOCCAL INFECTIONS.

Authors:  J O KLEIN; L D SABATH; B W STEINHAUER; M FINLAND
Journal:  N Engl J Med       Date:  1963-12-05       Impact factor: 91.245

2.  TREATMENT OF SEVERE STAPHYLOCOCCAL INFECTIONS WITH ANCILLIN.

Authors:  J O KLEIN; L D SABATH; B W STEINHAUER; M FINLAND
Journal:  Am J Med Sci       Date:  1963-10       Impact factor: 2.378

Review 3.  THE NEW PENICILLINS.

Authors:  J O Klein; M Finland
Journal:  N Engl J Med       Date:  1963-11-07       Impact factor: 91.245

4.  CEPHALOTHIN: ACTIVITY IN VITRO, ABSORPTION AND EXCRETION IN NORMAL SUBJECTS AND CLINICAL OBSERVATIONS IN 40 PATIENTS.

Authors:  J O KLEIN; T C EICKHOFF; J G TILLES; M FINLAND
Journal:  Am J Med Sci       Date:  1964-12       Impact factor: 2.378

5.  Methicillin treatment of severe staphylococcal disease. Observations in 146 cases.

Authors:  L D SABATH; B POSTIC; M FINLAND
Journal:  N Engl J Med       Date:  1962-11-22       Impact factor: 91.245

6.  THE DETECTION OF PENICILLINASE-PRODUCING PROPERTIES OF MICROORGANISMS.

Authors:  J S Gots
Journal:  Science       Date:  1945-09-21       Impact factor: 47.728

7.  Modified Gots test for penicillinase production.

Authors:  T H HAIGHT; M FINLAND
Journal:  Am J Clin Pathol       Date:  1952-08       Impact factor: 2.493

8.  Clinical evaluation of cephaloridine.

Authors:  N H Steigbigel; J W Kislak; J G Tilles; M Finland
Journal:  Arch Intern Med       Date:  1968-01

9.  Sensitivity of penicillinase-forming strains of Staphylococcus aureus and of their penicillinase-negative variants to cephaloridine, cephalothin, methicillin, and benzylpenicillin.

Authors:  J H Hewitt; M T Parker
Journal:  J Clin Pathol       Date:  1968-01       Impact factor: 3.411

10.  WILD-TYPE VARIANTS OF EXOPENICILLINASE FROM STAPHYLOCOCCUS AUREUS.

Authors:  M H RICHMOND
Journal:  Biochem J       Date:  1965-03       Impact factor: 3.857

  10 in total
  45 in total

1.  Disk with high oxacillin content discriminates between methicillin-resistant and borderline methicillin-susceptible Staphylococcus aureus strains in disk diffusion assays using a low salt concentration.

Authors:  A C Petersson; C Kamme; H Miörner
Journal:  J Clin Microbiol       Date:  1999-06       Impact factor: 5.948

2.  Detection of borderline oxacillin-resistant Staphylococcus aureus and differentiation from methicillin-resistant strains.

Authors:  H Liu; G Buescher; N Lewis; S Snyder; D Jungkind
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-10       Impact factor: 3.267

3.  Cefuroxime Resistance to Staphylococcal β-Lactamases.

Authors:  M Laverdiere; N Wheeler; L D Sabath
Journal:  Proc R Soc Med       Date:  1977

Review 4.  Reappraisal of the antistaphylococcal activities of first-generation (narrow-spectrum) and second-generation (expanded-spectrum) cephalosporins.

Authors:  L D Sabath
Journal:  Antimicrob Agents Chemother       Date:  1989-04       Impact factor: 5.191

5.  Comparison of the inoculum effects of members of the family Enterobacteriaceae on cefoxitin and other cephalosporins, beta-lactamase inhibitor combinations, and the penicillin-derived components of these combinations.

Authors:  E J Goldstein; D M Citron; C E Cherubin
Journal:  Antimicrob Agents Chemother       Date:  1991-03       Impact factor: 5.191

6.  Characterization of four beta-lactamases produced by Staphylococcus aureus.

Authors:  D J Zygmunt; C W Stratton; D S Kernodle
Journal:  Antimicrob Agents Chemother       Date:  1992-02       Impact factor: 5.191

7.  Prevalence of blaZ gene types and the inoculum effect with cefazolin among bloodstream isolates of methicillin-susceptible Staphylococcus aureus.

Authors:  D J Livorsi; E Crispell; S W Satola; E M Burd; R Jerris; Y F Wang; M M Farley
Journal:  Antimicrob Agents Chemother       Date:  2012-05-14       Impact factor: 5.191

8.  Activity of ten cephalosporins on biomass of methicillin-susceptible and -resistant Staphylococcus aureus.

Authors:  E Yourassowsky; M P Van der Linden; M J Lismont; F Crokaert
Journal:  Antimicrob Agents Chemother       Date:  1980-05       Impact factor: 5.191

9.  Efficacy of prophylaxis with beta-lactams and beta-lactam-beta-lactamase inhibitor combinations against wound infection by methicillin-resistant and borderline-susceptible Staphylococcus aureus in a guinea pig model.

Authors:  D S Kernodle; A B Kaiser
Journal:  Antimicrob Agents Chemother       Date:  1993-04       Impact factor: 5.191

10.  Inoculum effect of new beta-lactam antibiotics on Pseudomonas aeruginosa.

Authors:  R H Eng; S M Smith; C Cherubin
Journal:  Antimicrob Agents Chemother       Date:  1984-07       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.